OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors
Xujie Zhang, Lin Sun, Megan E. Meuser, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113848-113848
Open Access | Times Cited: 17
Xujie Zhang, Lin Sun, Megan E. Meuser, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113848-113848
Open Access | Times Cited: 17
Showing 17 citing articles:
HIV-1 Capsid Inhibitors: A Sword to Destroy the Virus
Xujie Zhang, Shujing Xu, Lin Sun, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 9, pp. 605-607
Closed Access | Times Cited: 12
Xujie Zhang, Shujing Xu, Lin Sun, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 9, pp. 605-607
Closed Access | Times Cited: 12
Discovery of novel 1,2,4‐triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein
Xiangyi Jiang, Prem Prakash Sharma, Brijesh Rathi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5975-5986
Open Access | Times Cited: 11
Xiangyi Jiang, Prem Prakash Sharma, Brijesh Rathi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5975-5986
Open Access | Times Cited: 11
The discovery and design of novel HIV-1 capsid modulators and future perspectives
Dang Ding, Shujing Xu, Xujie Zhang, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 1, pp. 5-12
Closed Access | Times Cited: 11
Dang Ding, Shujing Xu, Xujie Zhang, et al.
Expert Opinion on Drug Discovery (2022) Vol. 18, Iss. 1, pp. 5-12
Closed Access | Times Cited: 11
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators
Shujing Xu, Lin Sun, Michael J. Barnett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16303-16329
Open Access | Times Cited: 5
Shujing Xu, Lin Sun, Michael J. Barnett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16303-16329
Open Access | Times Cited: 5
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators
Xujie Zhang, Lin Sun, Shujing Xu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1272-1295
Open Access | Times Cited: 4
Xujie Zhang, Lin Sun, Shujing Xu, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1272-1295
Open Access | Times Cited: 4
Discovery of low‐molecular‐weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability
Xiangyi Jiang, Zhen Gao, Prem P. Sharma, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access | Times Cited: 1
Xiangyi Jiang, Zhen Gao, Prem P. Sharma, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access | Times Cited: 1
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins
Takuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
RSC Advances (2023) Vol. 13, Iss. 3, pp. 2156-2167
Open Access | Times Cited: 4
Takuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
RSC Advances (2023) Vol. 13, Iss. 3, pp. 2156-2167
Open Access | Times Cited: 4
Targeting the Virus Capsid as a Tool to Fight RNA Viruses
Lucie Hozáková, Barbora Vokatá, Tomáš Ruml, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 174-174
Open Access | Times Cited: 7
Lucie Hozáková, Barbora Vokatá, Tomáš Ruml, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 174-174
Open Access | Times Cited: 7
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
Xujie Zhang, Lin Sun, Shujing Xu, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7640-7640
Open Access | Times Cited: 7
Xujie Zhang, Lin Sun, Shujing Xu, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7640-7640
Open Access | Times Cited: 7
Nickel-Catalyzed Radical Heck-Type C(sp3)–C(sp2) Coupling Cascades Enabled by Bromoalkane-Directed 1,4-Aryl Shift: Access to Olefinated Arylalanines
Jian Liu, Yu Hong, Yin-Ling Liu, et al.
Organic Letters (2022) Vol. 24, Iss. 44, pp. 8192-8196
Closed Access | Times Cited: 6
Jian Liu, Yu Hong, Yin-Ling Liu, et al.
Organic Letters (2022) Vol. 24, Iss. 44, pp. 8192-8196
Closed Access | Times Cited: 6
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8415-8415
Open Access | Times Cited: 5
Shujing Xu, Lin Sun, Waleed A. Zalloum, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8415-8415
Open Access | Times Cited: 5
A Broad-Spectrum Antiviral Molecule, Protoporphyrin IX, Acts as a Moderator of HIV-1 Capsid Assembly by Targeting the Capsid Hexamer
Dawei Zhang, Liangxu Xie, Xiaoshuang Xu, et al.
Microbiology Spectrum (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Dawei Zhang, Liangxu Xie, Xiaoshuang Xu, et al.
Microbiology Spectrum (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Clade-Specific Alterations within the HIV-1 Capsid Protein with Implications for Nuclear Translocation
Alexej Dick, Megan E. Meuser, Simon Cocklin
Biomolecules (2022) Vol. 12, Iss. 5, pp. 695-695
Open Access | Times Cited: 3
Alexej Dick, Megan E. Meuser, Simon Cocklin
Biomolecules (2022) Vol. 12, Iss. 5, pp. 695-695
Open Access | Times Cited: 3
Chemical synthesis of a library of natural product-like derivatives based on pinnaic acid and initial evaluation of their anti-cancer activity
Alex Fudger, Okan M. Cakir, Yousaf Khan, et al.
Organic & Biomolecular Chemistry (2022) Vol. 20, Iss. 47, pp. 9408-9421
Open Access | Times Cited: 3
Alex Fudger, Okan M. Cakir, Yousaf Khan, et al.
Organic & Biomolecular Chemistry (2022) Vol. 20, Iss. 47, pp. 9408-9421
Open Access | Times Cited: 3
Comparative SPR Analysis of Intermolecular Interactions Performed Using the Original Biacore CM5 Chip and its Analog CMD500M
O.V. Gnedenko, П. В. Ершов, Yuri V. Mezentsev, et al.
Biomedical Chemistry Research and Methods (2024) Vol. 7, Iss. 2, pp. e00220-e00220
Open Access
O.V. Gnedenko, П. В. Ершов, Yuri V. Mezentsev, et al.
Biomedical Chemistry Research and Methods (2024) Vol. 7, Iss. 2, pp. e00220-e00220
Open Access
Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent
Jian-Jia Liang, Wulin Yu, Liang Yang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114313-114313
Closed Access | Times Cited: 2
Jian-Jia Liang, Wulin Yu, Liang Yang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114313-114313
Closed Access | Times Cited: 2
Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins
Takuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Chemical and Pharmaceutical Bulletin (2023) Vol. 72, Iss. 1, pp. 41-47
Open Access
Takuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, et al.
Chemical and Pharmaceutical Bulletin (2023) Vol. 72, Iss. 1, pp. 41-47
Open Access
